Second phase 3 trial of ridinilazole compared with vancomycin in patients with Clostridium-infections

Next Previous
Trial Profile

Second phase 3 trial of ridinilazole compared with vancomycin in patients with Clostridium-infections

Planning
Phase of Trial: Phase III

Latest Information Update: 27 Mar 2018

At a glance

  • Drugs Ridinilazole (Primary) ; Vancomycin
  • Indications Clostridium-difficile-infections
  • Focus Therapeutic Use

    • Most Recent Events

    • 27 Mar 2018 According to a Summit Therapeutics media release, this trial is planned to initiate in the Q1 2019.
    • 29 Mar 2017 According to a Summit Therapeutics media release, this trial is planned to initiate in the first half of 2018.
    • 03 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top